货号:GS40631
Rulonilimab is a humanized IgG1 monoclonal antibody targeting programmed cell death-1 (PD-1). It binds to PD-1 on T cells, blocking its interaction with PD-L1/PD-L2 ligands, thereby inhibiting downstream immunosuppressive signaling. This mechanism reverses T cell exhaustion and enhances anti-tumor immunity, positioning it as a potential immune checkpoint inhibitor for the treatment of various cancers.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯